홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Theophylline → Doxofylline

HRID 2243787
인쇄

반응식

HRID 2243787 반응식
C1C([CH2:4][N:5]2[C:15](=[O:16])[N:14]([CH2:17]C3CC3)[C:12](=[O:13])[C:7]3[N:8]=[C:9](N)[NH:10][C:6]2=3)C1.C[O:22][C:23]1C=CC(C2CNC(=O)NC2)=C[C:28]=1[O:29][C@@H:30]1[C@@H:35]2C[C@@H](CC2)C1.N1(C(=O)C2NC=NC=2N(C)C1=O)C.CC(CN1C(=O)N(C)C(=O)C2N=CNC1=2)C.CCCOC1C=C([C@@]2(C)OC(=O)NC2)C=CC=1OC.COC1C=C(C2C=CC(=O)NN=2)C=CC=1OC(F)F.CC[C@]12C=C(C(OCC)=O)N3C4=C(CCN([C@@H]14)CCC2)C1C=CC=CC=13.COC1C=CC(C2CNC(=O)C2)=CC=1OC1CCCC1.CCCN1C(=O)N(C2C=CC(Cl)=CC=2)C2NC=NC=2C1=O.C1C(C(NC2C(Cl)=CN=CC=2Cl)=O)=CC(OCC2CC2)=C(OC(F)F)C=1.CCOC1C=C2[C@H]3CN(C)CC[C@H]3N=C(C3C=CC(C(N(C(C)C)C(C)C)=O)=CC=3)C2=CC=1OC>>[CH3:4][N:5]1[C:15](=[O:16])[N:14]([CH3:17])[C:12](=[O:13])[C:7]2[N:8]([CH2:35][CH:30]3[O:22][CH2:23][CH2:28][O:29]3)[CH:9]=[N:10][C:6]1=2
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

12

반응물 11

HCID 2153TheophyllineHCID 5092RolipramHCID 5723ZardaverineHCID 443955VinpocetineHCID 449190MesopramHCID 449193RoflumilastHCID 3052763Pumafentrine
HCID 9861730
Atizoram
HCID 178448723HCID 178448723, 화합물
HCID 178456513HCID 178456513, 화합물
HCID 178508238HCID 178508238, 화합물

생성물 1

HCID 50942Doxofylline

실험 절차

Cipamfylline (HEP-688); atizoram (CP-80633); theophylline; isobutylmethylxanthine; Mesopram (ZK-117137); Zardaverine; vinpocetine; Rolipram (ZK-62711); Arofylline (LAS-31025); roflumilast (BY-217); Pumafentrin (BY-343);

출처 및 근거

ORD 기록
ord-a785069e7b9a4229bbe4913479bd65e7
출처 데이터셋
uspto-grants-2010_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07678363B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트